XTX Topco’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

XTX Topco’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-18,793	Closed	-$23.9K	–	2311
2023 Q3	$23.9K	Buy	+18,793	New	+$16.4K	﹤0.01%	1356
2022 Q1	–	Sell	-18,711	Closed	-$54K	–	1029
2021 Q4	$54K	Buy	+18,711	New	+$69.2K	0.03%	555

XTX Topco's ZYNE Position: Q4 2023 in Review

XTX Topco sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 18,793 shares — an estimated $23.9K sold.

XTX Topco first reported a position in ZYNE in Q4 2021 and held it in 2 quarters. The position peaked at $54K in Q4 2021. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

XTX Topco reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
XTX Topco sold 18,793 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $23.9K.
XTX Topco first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2021 and held it in 2 quarters.
XTX Topco's Zynerba Pharmaceuticals, Inc position peaked at $54K in Q4 2021.
0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on XTX Topco's 13F filing for Q4 2023, filed 13 Feb 2024.